Earnings Ahead

XFOR - X4 Pharmaceuticals, Inc

1.78 -0.08 -4.3

X4 Pharmaceuticals, Inc

X4 Pharmaceuticals, Inc

About

Profile


Headquarters


Intraday

High
-
Low
-

52-week

High
-
Low
-

XFOR



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • B. Riley cuts X4 to neutral, cites longer-term mavorixafor data
  • X4 Pharmaceuticals GAAP EPS of -$0.01 beats by $0.14
  • X4 Pharmaceuticals says CEO Paula Ragan sells 239.4K shares
  • X4 shares jump as FDA accepts priority review of pediatric WHIM drug
  • X4 submits New Drug Application to FDA for WHIM syndrome drug
  • X4 Pharmaceuticals GAAP EPS of -$0.33 misses by $0.16
  • X4 Pharmaceuticals rises as biotech set to join Russell 3000 Index
  • X4 Pharmaceuticals scales 12% on $65M private placement
  • X4 Pharmaceuticals GAAP EPS of -$0.16 beats by $0.05
  • X4 Pharma jumps 22% on upcoming data readout for lead asset
  • X4 Pharmaceuticals GAAP EPS of -$0.29 misses by $0.05
  • X4 Pharmaceuticals stock dips after pricing $65M securities offering
  • CTRM, NIU and GOTU among premarket losers
  • X4 Pharmaceuticals stock sheds 14% on proposed securities offering
  • X4 Pharma sheds 16% even as rare disease therapy meets main goal in Phase 3 trial
  • X4 Pharmaceuticals GAAP EPS of -$0.26 beats by $0.04
  • X4 stock rises 10% as mavorixafor shows promise in trial for white blood cell disorder
  • X4 Pharmaceuticals GAAP EPS of -$0.60 beats by $0.04
  • X4 Pharma to focus resources on lead drug candidate, cut workforce by about 20%
  • X4 Pharmaceuticals to raise $55M in stock and warrants offering, debt facility amended
Date Price Open High Low Vol Change ER
Mar 3 2.120 2.170
2.300
2.030
2.28M 7.61%
Mar 2 1.970 2.010
2.200
1.930
4.50M 9.44%
Mar 1 1.800 1.510
1.900
1.500
2.13M 20%
Feb 28 1.500 1.550
1.620
1.460
77.22K -3.23%
Feb 25 1.550 1.590
1.730
1.516
48.83K -2.52%
 
Feb 24 1.590 1.360
1.630
1.310
128.59K 7.43%
Feb 23 1.480 1.550
1.566
1.430
203.89K -3.9%
Feb 22 1.540 1.560
1.650
1.540
89.31K -1.28%
Feb 18 1.560 1.580
1.620
1.538
103.31K 0.65%
Feb 17 1.550 1.640
1.690
1.540
80.24K -6.06%
Feb 16 1.650 1.630
1.690
1.600
110.86K 1.23%
Feb 15 1.630 1.610
1.645
1.510
119.33K 3.82%
Feb 14 1.570 1.550
1.690
1.510
135.63K 0.64%
Feb 11 1.560 1.740
1.740
1.510
461.20K -9.3%
Feb 10 1.720 1.780
1.814
1.720
172.40K -6.01%
Feb 9 1.830 1.810
1.860
1.770
118.75K 4.57%
Feb 8 1.750 1.830
1.830
1.740
153.48K -3.31%
Feb 7 1.810 1.880
1.930
1.770
88.69K -2.16%
Feb 4 1.850 1.857
1.870
1.762
107.28K 3.35%